Eisai

About Eisai

Eisai is a global pharmaceutical company headquartered in the UK, dedicated to improving the health and well-being of people worldwide. Founded with a vision to create innovative medicines, Eisai focuses on the research and development of treatments for various diseases, particularly in the fields of oncology, neurology, and gastrointestinal disorders.

The company prides itself on its commitment to patient-centricity, ensuring that the needs of patients are at the forefront of its operations. Eisai’s extensive portfolio includes both prescription medications and over-the-counter products, catering to a diverse range of health conditions.

With a strong emphasis on research and development, Eisai invests significantly in clinical trials and collaborations with leading research institutions. This dedication to innovation has led to the discovery of several groundbreaking therapies that have transformed patient care.

Eisai operates in multiple countries, leveraging its global presence to enhance access to its products and services. The company is also committed to sustainability and corporate social responsibility, actively engaging in initiatives that promote environmental stewardship and community well-being.

• Core Areas: Oncology, Neurology, Gastrointestinal Disorders
• Commitment: Patient-Centricity, Innovation, Sustainability
• Global Presence: Operations in multiple countries

Through its unwavering dedication to healthcare excellence, Eisai continues to strive towards its mission of contributing to the health of society through the development of innovative medicines.